Search results
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 2 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 6 hours agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 2 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Bird Flu: 100 Million Doses of Vaccine Could Be Shipped Within Months
Healthline· 1 week agoThe U.S. government has two candidate vaccine viruses for H5N1 bird flu that could be used to make...
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about...
CBS News· 4 days agoMore than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing...
Q1 2024 Aclaris Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoSlide 12 shows the PK characteristics of...doses from five to 40 milligrams BID. Slide 14 shows exposure response analysis from the three PD. readouts in ...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris...
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
Benzinga· 2 days agoThe latest VLA1553-321 data confirmed that a single-dose vaccination with VLA1553 induced a high, sustained immune response with a seroresponse rate of ...
